Recent Price Movement and Market Context
On 19 Dec 2025, Entero Healthcare Solutions recorded a price drop of 1.43%, underperforming the Sensex, which posted a gain of 0.54% on the same day. This decline extends a four-day losing streak during which the stock has returned -3.72%. Over the past week, the stock has shown a negative return of -3.65%, compared to the Sensex's marginal fall of -0.38%. The one-month performance further emphasises the downward trend, with the stock registering a -11.35% return, while the Sensex remained relatively stable with a -0.29% return.
Over a three-month horizon, Entero Healthcare Solutions has recorded a -14.70% return, contrasting with the Sensex's positive 2.80% gain. The year-long performance reveals a more pronounced divergence, with the stock showing a -34.36% return against the Sensex's 7.22% rise. Year-to-date figures also highlight this disparity, as the stock has declined by -31.86%, whereas the Sensex has advanced by 8.71%.
Notably, the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained downward momentum. This technical positioning underscores the current market sentiment surrounding Entero Healthcare Solutions.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- - Highest rated stock selection
- - Multi-parameter screening cleared
- - Large Cap quality pick
Long-Term Performance and Comparative Analysis
Examining the longer-term performance, Entero Healthcare Solutions has not recorded any returns over the past three, five, and ten years, indicating a lack of capital appreciation during these periods. This contrasts sharply with the Sensex, which has delivered returns of 37.43% over three years, 80.88% over five years, and an impressive 232.85% over ten years.
Within the retailing sector, the stock's performance has been below par, with returns lagging behind broader market indices and sector benchmarks. The stock's market capitalisation grade stands at 3, reflecting its mid-tier size within the market context.
Financial Metrics and Operational Highlights
Despite the subdued stock price performance, Entero Healthcare Solutions exhibits several noteworthy financial characteristics. The company has demonstrated a strong capacity to service its debt, with a Debt to EBITDA ratio of 1.33 times, indicating manageable leverage levels relative to earnings before interest, taxes, depreciation, and amortisation.
Net sales have shown a compound annual growth rate of 30.10%, while operating profit has expanded at an annual rate of 127.38%, signalling robust growth in core business operations. The company has reported positive results for seven consecutive quarters, with the latest quarter recording a Profit After Tax (PAT) of Rs.31.60 crores, the highest to date.
Net sales for the most recent quarter reached Rs.1,570.95 crores, also a record high, alongside a PBDIT (Profit Before Depreciation, Interest, and Taxes) of Rs.62.06 crores. These figures highlight the company's ability to generate increasing revenues and operating profits despite the stock's downward trajectory.
Valuation and Institutional Holding
Entero Healthcare Solutions holds a Return on Capital Employed (ROCE) of 8.6%, accompanied by an Enterprise Value to Capital Employed ratio of 2.2, suggesting an attractive valuation relative to capital utilisation. The stock is currently trading at a discount compared to the average historical valuations of its peers within the sector.
Over the past year, while the stock price has declined by 34.36%, the company's profits have risen by 142%, resulting in a Price/Earnings to Growth (PEG) ratio of 0.3. This divergence between earnings growth and stock price performance is a notable feature of the company's recent financial profile.
Institutional investors hold a significant stake in Entero Healthcare Solutions, accounting for 24.32% of shareholding. These investors typically possess greater resources and analytical capabilities to assess company fundamentals compared to retail investors.
Is Entero Healthcare Solutions your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Summary of Current Situation
Entero Healthcare Solutions' stock price has reached an unprecedented low of Rs.960, reflecting a sustained period of price weakness that contrasts with the company's operational growth and profitability metrics. The stock's performance has lagged behind major indices such as the Sensex and sector benchmarks across multiple time frames, including one month, three months, one year, and year-to-date periods.
While the company continues to report record quarterly sales and profits, the market valuation has not aligned with these financial improvements. The stock trades below all major moving averages, indicating persistent downward momentum in market sentiment. Institutional ownership remains substantial, suggesting continued interest from significant market participants.
Overall, Entero Healthcare Solutions presents a complex picture where financial growth and operational results coexist with a challenging stock price environment, culminating in the recent all-time low.
Only Rs. 14,999 - Get MojoOne + Stock of the Week for 1 Year PLUS 18 Months FREE! Start Saving Now →
